Results 241 to 250 of about 196,807 (276)

Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies

Cancer Science, EarlyView.
Mass spectrometry‐based phosphoproteomics for mechanistic dissection of cancer signaling pathways and uncovering therapeutic vulnerabilities. ABSTRACT Protein phosphorylation is a central post‐translational modification regulating cellular signaling, frequently dysregulated in cancer.
Hirokazu Shoji, Narikazu Boku, Jun Adachi   +2 more
wiley   +1 more source

Capillary Hemangioma of the Breast Parenchyma Mimicking New Primary Cancer or Metastasis During Ramucirumab Therapy for Advanced Gastric Cancer. [PDF]

In Vivo
Kim HB, Lee YA, Kim SH, Park SG.
europepmc   +1 more source

Four‐Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI‐52

Cancer Science, EarlyView.
This follow‐up study for TASUKI‐52 trial demonstrates the 4‐year beneficial efficacy of nivolumab (NIV) combined with chemotherapy (CP) and bevacizumab (BEV) in patients with nonsquamous non‐small cell lung cancer (NSCLC) and reveals potential patient backgrounds associated with long‐term survival.
Jong‐Seok Lee, Shunichi Sugawara, Jin‐Hyoung Kang, Hye Ryun Kim, Naoki Inui, Toyoaki Hida, Ki Hyeong Lee, Tatsuya Yoshida, Hiroshi Tanaka, Cheng‐Ta Yang, Takako Inoue, Makoto Nishio, Yasushi Goto, Tomohide Tamura, Nobuyuki Yamamoto, Chong‐Jen Yu, Hiroaki Akamatsu, Shigeru Takahashi, Kazuhiko Nakagawa   +18 more
wiley   +1 more source

Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis. [PDF]

Ther Adv Med Oncol
Qian X, Chen X, Xiao M, Ji L, Li Q, Wang J, Fan Y, Luo Y, Cai R, Lan B, Chen S, Ma F, Xu B, Zhang P.   +13 more
europepmc   +1 more source

Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09). [PDF]

EClinicalMedicine
Yuan H, Lu S, Sun DB, Yao XX, Liu WT, Zheng YN, Hua ZC, Ni ZT, He CY, Wang ZQ, Zhang J, Liu D, Jiang C, Li C, Zhang J, Yan M, Yang ZY, Shi M, Zhu ZG, Yan C.   +19 more
europepmc   +1 more source

Skin Metastasis from Cervical Adenocarcinoma with Intrapulmonary Metastasis and Metachronous Ovarian Cancer Responding to Chemotherapy: A Case Report and Review. [PDF]

Cancer Manag Res
Sutedja EK, Sutedja E, Ruchiatan K, Faldian Y, Suwarsa O, Anandita R, Usman HA, Ala NMI.   +7 more
europepmc   +1 more source

Pharmacokinetic-Pharmacodynamic Model of Paclitaxel-Induced Peripheral Neuropathy. [PDF]

Clin Transl Sci
Sun Y, Pai MP, Henry NL, Hertz DL.
europepmc   +1 more source

Peripheral artery disease and local drug delivery: a review of disease pathology and drug delivery systems for therapy below the knee. [PDF]

Exp Biol Med (Maywood)
Akers NM, Dugas TR.
europepmc   +1 more source

Licoricidin Enhances Paclitaxel-induced Apoptosis Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells. [PDF]

In Vivo
Tai CT, Chen YC, Hsieh YH, Lin CL, Ying TH, Chen JC.   +5 more
europepmc   +1 more source